Suryansh Bajaj

Suryansh Bajaj

Auto-generated profile, based on publicly available information

Suryansh Bajaj

Department of Radiology, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2022 in Radiology
Verified
Journal Article
Closed access
XWXiao Wu
Xiao Wu
SBSuryansh Bajaj
Suryansh Bajaj
MKMihir Khunte
Mihir Khunte
MRMargarita Revzin
Margarita Revzin
DGDheeraj Gandhi
Dheeraj Gandhi
AMAjay Malhotra
Ajay Malhotra
Identifying reasons for the low proportion of female and underrepresented minority radiology residency applicants, despite a highly diverse pool of medical students, would be key to increasing thei... Background There have been growing efforts nationally and institutionally toward diversity in radiology. Purpose To analyze sex and racial and ethnic diversity over time (2010–2019) for the various...

28 September 2021 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
SBSuryansh Bajaj
Suryansh Bajaj
NGNeethu Gopal
Neethu Gopal
MCMary J. Clingan
Mary J. Clingan
SBShweta Bhatt
Shweta Bhatt

27 July 2023 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
PPP. Prajapati
P. Prajapati
XWXiao Wu
Xiao Wu
SBS. Bajaj
S. Bajaj
DGDheeraj Gandhi
Dheeraj Gandhi
MWMax Wintermark
Max Wintermark
AMAjay Malhotra
Ajay Malhotra
SUMMARY: Radiology has historically not been a very diverse field. Many steps have been taken in the past decade to increase diversity in the field and make it more inclusive. This study shows the relative trends specifically in neuroradiology trainees, and the need for reassessment and further steps to increase diversity.

1 September 2023 in Radiology
Verified
Journal Article
Closed access
AKAmin Khan
Amin Khan
SBSuryansh Bajaj
Suryansh Bajaj
MKMihir Khunte
Mihir Khunte
Sam PayabvashSam Payabvash
Sam Payabvash
MWMax Wintermark
Max Wintermark
AMAjay Malhotra
Ajay Malhotra
Background Radiology ranks high in terms of specialties implicated in medical malpractice claims. While most radiologists understand the risks of liability for missed findings or lapses of communication, liability for the use of contrast agents in imaging procedures may be underappreciated. Purpose To review the clinical context and outcomes of lawsuits alleging medical malpractice for contrast-related imaging procedures. Materials and Methods Two large U.S. legal databases were queried using the terms "Contrast" and "Radiology OR Radiologist" from database inception to October 31, 2022, to identify cases with published decisions or settlements related to medical malpractice in patients who underwent contrast-related imaging procedures. The search results were screened to include only those cases involving the practice area of health care law where there was at least one claim of medical negligence against a health care institution or provider. Data on the medical complications alleged by patients after contrast agent administration and on the trial were extracted and reported using descriptive statistics. Results A total of 151 published case summaries were included in the analysis. Anaphylactic reaction following contrast agent administration was the most common medical complication observed (30% [45 of 151 cases]), of which failure to diagnose developing anaphylaxis or failure to treat the anaphylactic reaction made up the majority of allegations (93% [42 of 45]). Inappropriate management of contrast media extravasation (27% [41 of 151]) and alleged contrast agent-induced acute kidney injury (13% [19 of 151]) were the next most frequent causes of lawsuits. Of the 11 cases of alleged kidney injury that went to trial, all resulted in a judgment in favor of the defense. Conclusion This study highlights the key reasons for medical malpractice lawsuits associated with use of contrast media and outcomes from these lawsuits. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Trop in this issue.

23 November 2024 in Journal of Vascular and Interventional Radiology
Verified
Journal Article
Open access
CMChristopher Malone
Christopher Malone
SBSuryansh Bajaj
Suryansh Bajaj
AHAiwu He
Aiwu He
KMKabir Mody
Kabir Mody
RHRyan M. Hickey
Ryan M. Hickey
BTBeau B. Toskich
Beau B. Toskich
Hepatocellular carcinoma is a leading and increasing contributor to cancer-related death worldwide. Recent advancements in both liver-directed therapies in the form of yttrium-90 (90Y) radioembolization (RE) and systemic therapy in the form of immune checkpoint inhibitors (ICI) have expanded treatment options for patients with an otherwise poor prognosis. Despite these gains, ICIs and 90Y-RE each have key limitations with low objective response rates and persistent hazard of out-of-field recurrence, respectively, and overall survival remains low. However, each therapy's strength may mitigate the other's weakness, making them potentially ideal partners for combination treatment strategies. This review discusses the scientific and clinical rationale for combining 90Y-RE with ICIs, highlights early clinical trial data on its safety and effectiveness, and proposes key issues to be addressed in this emerging field. With optimal strategies, combination therapies can potentially result in increasing likelihood of durable and curative outcomes in later stage patients.

11 August 2023 in Journal of the American College of Radiology
Verified
Journal Article
Closed access
SBSuryansh Bajaj
Suryansh Bajaj
MKMihir Khunte
Mihir Khunte
NMNagaraj S. Moily
Nagaraj S. Moily
Sam PayabvashSam Payabvash
Sam Payabvash
MWMax Wintermark
Max Wintermark
AMAjay Malhotra
Ajay Malhotra